Commonwealth v. Ortho-McNeil-Janssen Pharmaceuticals, Inc.

30 Mass. L. Rptr. 377
CourtMassachusetts Superior Court
DecidedOctober 5, 2012
DocketNo. SUCV201102811BLS2
StatusPublished

This text of 30 Mass. L. Rptr. 377 (Commonwealth v. Ortho-McNeil-Janssen Pharmaceuticals, Inc.) is published on Counsel Stack Legal Research, covering Massachusetts Superior Court primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Commonwealth v. Ortho-McNeil-Janssen Pharmaceuticals, Inc., 30 Mass. L. Rptr. 377 (Mass. Ct. App. 2012).

Opinion

Sanders, Janet L., J.

This is an action pursuant to G.L.c. 93A, §4 alleging that the defendant Ortho-McNeil-Janssen Pharmaceuticals, Inc. (Janssen) engaged in unfair and deceptive trade practices in the marketing and sale of Risperdal, an anti-psychotic medication. The action was initiated by the Attorney General of the Commonwealth on behalf of Massachusetts consumers who have used the drug as well as all health care professionals (public and private) who have prescribed it. Before the Court are defendant’s Motion to Compel Discovery and the Commonwealth’s [378]*378Cross Motion for a Protective Order. The principal issue raised by both motions is whether the Attorney General’s obligation to search for and produce documents responsive to defendant’s discovery requests extends to other departments and agencies within the executive branch. For reasons set forth below, this Court concludes that her discovery obligations are limited to producing documents in the possession of her office.

The instant motions stem from Janssen’s First Request for Production of Documents, served on the Commonwealth on February 17, 2012. In the Definitions Section of those Requests, Janssen made clear that, in seeking documents from the “Commonwealth,” it expected production from all “political subdivisions, departments, or agencies thereof,” including but not limited to fifteen named state entities. Among those agencies included are MassHealth (which administers Medicaid and other health care coverage programs), the Department of Correction (which provides health care services to its inmate population), and the Department of Mental Health (providing care for mentally ill Massachusetts citizens). What followed were 95 separate requests for documents that sought information in the possession, custody, or control of these agencies dating back to December 1993.

The requests are also breathtakingly broad in scope. For example, several requests seek the production of all documents relating to any antipsychotics, not just Risperdal. One request seeks documents relating to any statement made to the Commonwealth (as broadly defined) by any patient or guardian in Massachusetts who has taken Risperdal at any time. Three other requests identify over fifty different programs within the Commonwealth from which Janssen seeks documents regarding their policies and procedures for prescribing antipsychotic medications. The requests seek minutes, calendars, attendance sheets and agendas for any “Commonwealth” meetings, communications by any “Commonwealth” representative with a host of federal agencies, protocols for the treatment of schizophrenia in any government-run health care facility, and the entire MassHealth claims data base.

The Attorney General responded to the Requests by producing 1,430 documents, 1,385 of which were general document retention policies. It also lodged both general and specific objections to the Requests. Its motion seeks a court ruling as to some (but not all) of those objections. First (and most significant for purposes of these motions), the Attorney General objects to production of documents from any other state agency, maintaining that these entities are not parties to the case and that her discovery obligations extended no further than the confines of the Healthcare Division of her office which undertook this prosecution. Second, the Attorney General objects to producing documents already in the possession of Janssen, particularly those documents Janssen produced pursuant to a Civil Investigative Demand made on the company. Finally, the Attorney General objects to Request No. 77 regarding document preservation and retention policies dating back to 1993. This Court’s rulings on each objection are set forth below.

1. Who is the plaintiff?

In arguing that it is entitled to document production from all state political subdivisions and agencies, Janssen contends that the plaintiff in this action is the Commonwealth of Massachusetts and thus the discovery obligations necessarily extend to all those within state government. Although the Attorney General is the chief law enforcement officer responsible for bringing and defending lawsuits in the name of the Commonwealth, Janssen argues that neither she nor the division which initiated this case is the Commonwealth, only the Commonwealth’s attorney. In addition, Janssen notes that Rule 34, Mass.R.Civ.P., does not limit a party’s discovery obligation to those documents in its physical possession but extends to documents over which the party has control. Janssen maintains that the Attorney General has legal control over other state agencies pursuant to G.L.c. 12 , §3 (which requires her to represent agencies in court) and is able to access their documents as a practical matter. Finally, Janssen argues that the state agencies from which it seeks discovery include health care professionals or serve populations on whose behalf this suit is brought. In order to defend itself from the claim of unfair and deceptive practices, Janssen says that it needs access to documents relating to these health care providers’ prescription of the Risperdal and information concerning those who received it as part of any government program.

The Attorney General responds that she brings this suit not because of her legal obligation to represent a particular state agency in a civil action but because of the independent authority granted to her under G.L.c. 93A, §4 to act in the public interest and protect consumers from unfair business practices. Accordingly, state agencies are not themselves parties, nor does the Attorney General have any particular power to demand that they search for documents responsive to Janssen’s Requests. To require her to seek production of documents from these other agencies (it is contended) would be not only unduly burdensome but also possibly put the Attorney General at loggerheads with the governor, who heads the executive branch. Finally, the Attorney General argues that the documents themselves are unlikely to contain information relevant to the dispute at hand. Although there is a paucity of case law to guide this Court, I am more persuaded by the Commonwealth’s arguments than those propounded by Janssen.

The handful of decisions (none in Massachusetts) dealing with this question reflect some common concerns.1 The first stems from the recognition that all [379]*379agencies and departments within the executive branch do not speak with a single voice. In fact, they have different functions and spheres of responsibility, and some operate as quasi independent agencies. This notion that agencies are not part of a monolithic whole was the decisive consideration in New York v. National R.R. Passenger Corp, 233 F.R.D. 259 (N.D.N.Y. 2006). In that case, the court held that the defendant Amtrak was not entitled to obtain discovery from the New York Office of the State Comptroller (OSC), since the OSC operated as an independent agency over which the Attorney General (who had initiated the suit) exercised no control. Citing principles of federalism and comity, the court went on to say that “there is a presumption that separate governmental agencies under state law will not be aggregated together, without the showing of much more.” Id. at 264. In the instant case, Janssen’s Requests do not differentiate between state agencies, much less make any particularized showing that the Attorney General has any control over them, other than to point out that she is bound by statute to serve as their lawyer if they are sued or wish to bring suit in state court. See G.L.c. 12, §3.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Aspinall v. Philip Morris Companies, Inc.
442 Mass. 381 (Massachusetts Supreme Judicial Court, 2004)
New York v. National Railroad Passenger Corp.
233 F.R.D. 259 (N.D. New York, 2006)

Cite This Page — Counsel Stack

Bluebook (online)
30 Mass. L. Rptr. 377, Counsel Stack Legal Research, https://law.counselstack.com/opinion/commonwealth-v-ortho-mcneil-janssen-pharmaceuticals-inc-masssuperct-2012.